TRVI
Trevi Therapeutics Inc
14.50$
-5.1%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | +164.3% | -7.8% | +192.8% | -21.4% | -18.4% | +219.7% | -27.3% | +24.0% | +74.4% | |
| – | +164.1% | -15.2% | +217.0% | -22.3% | -18.0% | +223.0% | -28.6% | +25.0% | +75.1% | |
| – | +165.7% | -22.0% | +233.9% | -21.5% | -18.2% | -65.8% | +157.3% | +5.2% | -44.5% | |
| – | +165.7% | -22.0% | +233.9% | -21.5% | -18.2% | +227.2% | -31.2% | +29.7% | +74.9% | |
| – | +221.1% | +201.6% | +203.3% | -52.5% | -9.1% | – | – | – | +85.3% | |
| – | – | +2,115.9% | +14.9% | -44.2% | -126.9% | – | – | – | – | |
| – | +180.0% | +964.3% | +188.6% | -23.3% | -44.2% | -7.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -71.1% | -57.3% | +71.5% | +263.8% | +7.8% | -27.3% | -55.9% | +64.2% | -9.4% | |
| – | -65.1% | -62.4% | +94.3% | +6.8% | +129.1% | +5.3% | -56.5% | +80.4% | -7.2% | |
| – | -68.9% | -100.0% | – | +14.1% | +5,168.1% | +18.0% | -95.6% | -6.9% | +7.7% | |
| – | +20.7% | +12.3% | +165.2% | +26.1% | +41.3% | +0.3% | -36.7% | +88.7% | +14.6% | |
| – | -100.0% | – | – | – | -38.0% | -75.1% | – | – | – | |
| – | – | +17.1% | +215.2% | -50.0% | -37.4% | +529.3% | -23.2% | +20.7% | +83.9% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -44.4% | +0.0% | +98.9% | +1.3% | +26.5% | +182.6% | +53.4% | +2.0% | +43.6% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.